首页> 外文学位 >Crystal structures and mechanisms of two enzymes involved in the degradation of tyrosine and biphenyl
【24h】

Crystal structures and mechanisms of two enzymes involved in the degradation of tyrosine and biphenyl

机译:酪氨酸和联苯降解中涉及的两种酶的晶体结构和机理

获取原文
获取原文并翻译 | 示例

摘要

Homogentisate 1,2-dioxygenase (HGO), the third enzyme in tyrosine degradation, is an extradiol-type dioxygenase that utilizes nonheme Fe(II) and dioxygen to catalyze the ring cleavage of homogentisate (HGA). Its chemical mechanism may be studied by structural and biochemical approaches. Crystal structures of anaerobically prepared human HGO and the HGO:HGA complex have been determined to 1.6 and 1.8 A resolution. The structure of the HGO:HGA complex shows that the substrate binds at the active site in a mode that differs from that predicted by a prior modeling study. Based on the structure, a revised mechanism is proposed. HGO is a potential target of inhibition to treat hepatorenal tyrosinemia type 1 (HT1). Biochemical data indicated that 3-Cl HGA is an effective inhibitor of human HGO and the structure of HGO:3-Cl HGA complex has been determined to 1.7 A resolution to understand the inhibition. 3-Cl HGA binds differently than the substrate, which suggests that the slow catalysis may be due to the predominant non-productive binding mode in the crystal structure.;The activity of 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate (HOPDA) hydrolase (BphD), a C-C bond hydrolase, is a key determinant in the aerobic transformation of polychlorinated biphenyls (PCBs). The failure of the bph pathway to efficiently process PCBs and PCB metabolites limits strategies for bioremediation. We study mechanisms of BphD catalysis and catalytic failure using structural and biochemical approaches. Crystal structures of BphD LB400 (BphD from Burkholderia strain LB400), its S112C mutant, the S112C:HOPDA complex, and S112A mutant have been determined at 1.6 A resolution. BphDLB400 is a tetramer. Each monomer has a typical alpha/beta hydrolase fold and is divisible into core and lid domains. The active site is located between the two domains and consists of polar and non-polar parts including a catalytic triad, S112-H265-D237. The mechanism of C-C bond hydrolases is a subject of debate. Recent biochemical evidence favors a mechanism that generates a gem-diol intermediate following base-catalyzed attack by water. In the S112C:HOPDA structure, C112 covalently binds HOPDA at the C6 position, forming a complex that resembles a tetrahedral intermediate consistent with a protein-nucleophile mechanism.
机译:酪氨酸降解中的第三种酶-纯柠檬酸1,2-二加氧酶(HGO)是一种利用非血红素Fe(II)和双氧催化高纯柠檬酸(HGA)环裂解的胞外二醇型双加氧酶。可以通过结构和生化方法研究其化学机理。厌氧制备的人类HGO和HGO:HGA复合物的晶体结构已确定为1.6和1.8 A分辨率。 HGO:HGA配合物的结构表明,底物以与先前建模研究预测的模式不同的方式在活性位点结合。基于该结构,提出了一种修正机制。 HGO是治疗1型肝肾酪氨酸血症(HT1)的潜在抑制目标。生化数据表明3-Cl HGA是人类HGO的有效抑制剂,HGO:3-Cl HGA复合物的结构已确定至1.7 A的分辨率以了解其抑制作用。 3-Cl HGA与底物的结合方式不同,这表明缓慢的催化作用可能是由于晶体结构中主要的非生产性结合方式所致; 2-羟基-6-氧代-6-苯基六-2的活性, 4-二烯酸(HOPDA)水解酶(BphD)是CC键水解酶,是多氯联苯(PCB)有氧转化的关键决定因素。 bph途径无法有效处理PCBs和PCB代谢产物,限制了生物修复策略。我们使用结构和生化方法研究BphD催化和催化失败的机制。已确定BphD LB400(伯克霍尔德菌菌株LB400的BphD),其S112C突变体,S112C:HOPDA复合物和S112A突变体的晶体结构为1.6 A分辨率。 BphDLB400是四聚体。每个单体都有一个典型的α/β水解酶折叠,可分为核心和盖子区域。活性位点位于两个结构域之间,由极性和非极性部分组成,包括催化三联体S112-H265-D237。 C-C键水解酶的机理尚有争议。最近的生化证据支持一种在碱催化的水攻击后生成宝石二醇中间体的机制。在S112C:HOPDA结构中,C112在C6位置共价结合HOPDA,形成类似于蛋白质亲核机理的四面体中间体的复合物。

著录项

  • 作者

    Ke, Jiyuan.;

  • 作者单位

    Purdue University.;

  • 授予单位 Purdue University.;
  • 学科 Molecular biology.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 132 p.
  • 总页数 132
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号